Lidia Ruiz Tabuenca
Coordinador/a dels serveis cientificotècnics
Supervisor/a de laboratori
Coordinadora de Serveis cientificotècnics i Lab Manager
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progression.
Immunotherapy and therapeutic vaccines in HIV infection.
Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene.
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries.
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients.